It has been demonstrated that defective mTOR-TFEB signaling is involved in the progression of RagCS75Y mutated cardiomyopathy, which can only be corrected by overexpression of TFEB but not inhibition of mTOR (Kim et al., 2021). The gene discussed is TFEB; the disease is cardiomyopathy.